Literature DB >> 25901205

Combined histological and hematological assessment of iron-induced organ damage in a gerbil model of iron overload.

Man Wang1, Rong-Rong Liu1, Cong-Jun Wang2, Wei Kang3, Gao-Hui Yang1, Wu-Ning Zhong3, Yong-Rong Lai1.   

Abstract

BACKGROUND: Previous studies with gerbil models have suggested that excessive iron exposure causes cardiomyopathy and hepatic injury, but pathological analysis was not comprehensive, preventing a detailed understanding of how the metal induces this damage. METHODS AND
RESULTS: Gerbils received single intraperitoneal injections of iron dextran (200 mg/kg) or saline and were then analyzed comprehensively for hematological and histological signs of organ damage. These tests included hematology parameters and determination of liver iron concentration, malondialdehyde levels and glutathione peroxidase activity; examination of heart and liver tissue stained with hematoxylin and eosin, Prussian-blue and Masson stain; and electron microscopy analysis of heart and liver ultrastructure. Iron-overloaded animals showed significantly different hematology parameters and significantly higher liver iron concentrations than saline-injected animals, as well as significantly higher malondialdehyde levels and significantly lower glutathione peroxidase activity. Histology analyses showed cellular damage, iron deposits, and both myocardial and liver fibrosis, while electron microscopy of heart and liver sections showed abundant iron deposition lysosomes, and disordered and swollen mitochondria. All these pathological changes increased with exposure time.
CONCLUSIONS: This comprehensive assessment of iron overload in a gerbil model suggests that excessive iron deposition induces extensive cellular damage, particularly fibrosis in heart and liver. This damage may be the direct result of iron-mediated lipid peroxide damage and of iron deposition that cause compression of myocardial and liver cells, as well as vascular occlusion.

Entities:  

Keywords:  Iron overload; fibrosis; lipid peroxidation; oxidative stress; ultrastructure

Year:  2015        PMID: 25901205      PMCID: PMC4399101     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  31 in total

1.  Disorders of iron metabolism.

Authors:  P A Andrews
Journal:  N Engl J Med       Date:  2000-04-27       Impact factor: 91.245

Review 2.  Iron overload cardiomyopathy in clinical practice.

Authors:  Dimitrios T Kremastinos; Dimitrios Farmakis
Journal:  Circulation       Date:  2011-11-15       Impact factor: 29.690

3.  Mitochondrial dysfunction may explain the cardiomyopathy of chronic iron overload.

Authors:  Xueshan Gao; Mingwei Qian; Jian Li Campian; James Marshall; Zhanxiang Zhou; Andrew M Roberts; Y James Kang; Sumanth D Prabhu; Xiao-Feng Sun; John W Eaton
Journal:  Free Radic Biol Med       Date:  2010-05-05       Impact factor: 7.376

4.  Iron overload-induced rat liver injury: Involvement of protein tyrosine nitration and the effect of baicalin.

Authors:  Yan Zhang; Yi Huang; Xiaorong Deng; Yan Xu; Zhonghong Gao; Hailing Li
Journal:  Eur J Pharmacol       Date:  2012-01-28       Impact factor: 4.432

Review 5.  Iron uptake and metabolism in the new millennium.

Authors:  Louise L Dunn; Yohan Suryo Rahmanto; Des R Richardson
Journal:  Trends Cell Biol       Date:  2006-12-27       Impact factor: 20.808

6.  Deferoxamine promotes survival and prevents electrocardiographic abnormalities in the gerbil model of iron-overload cardiomyopathy.

Authors:  Carlos A Obejero-Paz; Tianen Yang; Wei-Qiang Dong; Matthew N Levy; Gary M Brittenham; Yuri A Kuryshev; Arthur M Brown
Journal:  J Lab Clin Med       Date:  2003-02

Review 7.  Iron overload cardiomyopathies: new insights into an old disease.

Authors:  P Liu; N Olivieri
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

8.  Iron overload causes osteoporosis in thalassemia major patients through interaction with transient receptor potential vanilloid type 1 (TRPV1) channels.

Authors:  Francesca Rossi; Silverio Perrotta; Giulia Bellini; Livio Luongo; Chiara Tortora; Dario Siniscalco; Matteo Francese; Marco Torella; Bruno Nobili; Vincenzo Di Marzo; Sabatino Maione
Journal:  Haematologica       Date:  2014-09-12       Impact factor: 9.941

9.  Antioxidant-mediated effects in a gerbil model of iron overload.

Authors:  Maya Otto-Duessel; Michelle Aguilar; Rex Moats; John C Wood
Journal:  Acta Haematol       Date:  2007-10-16       Impact factor: 2.195

10.  Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.

Authors:  Dimitrios Th Kremastinos; Eftihia Hamodraka; John Parissis; Dimitrios Tsiapras; Kleanthi Dima; Alan Maisel
Journal:  Am Heart J       Date:  2010-01       Impact factor: 4.749

View more
  3 in total

Review 1.  Involvement of cytosolic and mitochondrial iron in iron overload cardiomyopathy: an update.

Authors:  Richard Gordan; Suwakon Wongjaikam; Judith K Gwathmey; Nipon Chattipakorn; Siriporn C Chattipakorn; Lai-Hua Xie
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

Review 2.  From Iron Metabolism to Ferroptosis: Pathologic Changes in Coronary Heart Disease.

Authors:  Xinbiao Fan; Aolin Li; Zhipeng Yan; Xiaofei Geng; Lu Lian; Hao Lv; Dongjie Gao; Junping Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-08-10       Impact factor: 7.310

3.  Artificial local magnetic field inhomogeneity enhances T2 relaxivity.

Authors:  Zijian Zhou; Rui Tian; Zhenyu Wang; Zhen Yang; Yijing Liu; Gang Liu; Ruifang Wang; Jinhao Gao; Jibin Song; Liming Nie; Xiaoyuan Chen
Journal:  Nat Commun       Date:  2017-05-18       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.